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DFT calculationsAbstract Among relevant metal ions in biological systems, zinc and iron play a key role as active
partners of the catalytic machinery. In particular, the inhibition of metal enzymes that are involved
in physiological and pathological processes has been deeply investigated for the rational design of
selective and efficient drugs based on chelators. Since imidazole histidine residue is one of the most
versatile sites in proteins, especially in enzymes acting in the presence of metal ions as cofactors, in
this work the synthesis and characterization of a new imidazole derivative, namely 5-methyl-2-
phenoxymethyl-3-H-imidazole-4-carboxylic acid (PIMA) is reported. PIMA was designed as
metallo-b-lactamase inhibitor thanks to its similarity with penicillin V, a b-lactam antibiotic inac-
tivated by metallo-b-lactamase, for which there are no commercially available inhibitors. The eval-
uation of PIMA coordinating ability toward iron, zinc, and gallium, these latter selected as a non-
paramagnetic probe for iron, is performed by theoretical DFT calculations and in solution by
experimental techniques, i.e. potentiometry, UV–vis and NMR spectroscopy. PIMA exhibits an
efficient metal chelating ability; the prevailing species in physiological condition are ML3 for
Fe3+ and Ga3+ and ML2 for Zn
2+, in which chelation is due to deprotonated carboxylic oxygen
and imidazole nitrogen in the N,O donor set. The demonstrated ability of PIMA to chelate zinc ion,
OO
P
Scheme 1 Structural similari
1062 C. Romagnoli et al.combined with its structure similarity with penicillin V, supports further exploration of this
imidazole-4-carboxylate as metallo-b-lactamase inhibitor.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Imidazole histidine residue is one of the most versatile sites in
proteins, especially in enzymes acting in the presence of metal
ions as co-factors (Kapinos et al., 1998; Uchida, 2003; Remko
et al., 2010; Li et al., 2010). The biological importance of imi-
dazole moiety is therefore connected with its metal coordina-
tion ability; the metal complexes with several imidazole-
containing ligands have also been studied as structural models
for active sites of metallo-enzymes (Kimura et al., 1991; Jiang
et al., 2006; Tagaki et al., 1993). Among relevant metal ions in
biological systems, we can find zinc and iron, which represent
the active partners of the catalytic machinery. These enzymes
are involved in several physiological and pathological pro-
cesses, and their inhibition, mainly based on metal chelation,
has been deeply investigated for the rational design of selective
and efficient drugs. For instance, within the family of zinc
dependent enzymes, many efforts are reported for the inhibi-
tion of carbonic anhydrase, involved in edema and epilepsy
(Alterio et al., 2012), matrix metallo-proteinases, for the treat-
ment of pathologies such as arthritis and cancer (Dorman
et al., 2010), or metallo-b-lactamases, to contrast the serious
threat of antibiotic resistance (Phelan et al., 2014). Iron home-
ostasis involves a large number of proteins; thus, understand-
ing their mechanisms of action allows the development of
drugs useful for the treatment of pathologies related to iron
dysregulation. Pharmacological strategies always include the
formation of iron-chelate complexes that could compete with
the biological storage sites of the metal itself. In addition, iron
chelators may also be useful as anti-tumor agents, since they
are able to deplete labile iron pool or cause oxidative stress
in the tumor due to redox perturbations in its environment
(Buss et al., 2003). Recently, studies have been conducted on
neuroglobin, a new member of hemoprotein family, which
takes part in many biological processes such as enzymatic reac-
tions, signal transduction and the mitochondria function (Xu
et al., 2009). As neuroglobin is associated with the mitochon-
dria function, its potential therapeutic application in Alzhei-N
S
COOH
H
N
O
Metallo-β-lactam
enicillin V
ty of 5-methyl-2-phenoxymethyl-mer’s disease and neurodegenerative disorders has been
recently suggested (Liu et al., 2009). Differently from myo-
globin and hemoglobin, neuroglobin has a hexacoordinated
heme environment, with histidyl imidazole of proximal His96
and distal His64 directly bound to the metal ion.
The presence of substituents on the imidazole ring influ-
ences the basicity at the protonated nitrogen and this reflects
on metal ligating ability. An interesting imidazole derivative
is imidazole-4-acetic acid (IMA) which is a metabolite of his-
tamine (Schayer, 1952) and histidine (Baldridge and
Tourtellotte, 1958). This compound occurs in the brain of
mammals and acts as a receptor activated by an inhibitor of
neurotransmission-gamma-aminobutyric acid (GABA). It
belongs to a newly separated class of receptors namely GABAc
receptors whose action is modulated by transition metal ions
(Ni2+, Cu2+, Cd2+, Zn2+) (Vien et al., 2002). From the
bioinorganic point of view, IMA forms stable complexes with
metal ions of biological relevance (Kurdziel et al., 2003; Sanna
et al., 1998; Aljahdali et al., 2013). The presence of the azome-
thine nitrogen and carboxylic oxygen atoms in the molecule
allows forming chelate complexes with metal ions although
the crystal structure of Zn-IMA complex shows a polymeric
arrangement (Dro_zd _zewski et al., 2002).
This study reports the synthesis and characterization of a
new imidazole derivative, namely 5-methyl-2-phenoxymethyl-
3H-imidazole-4-carboxylic acid (PIMA), shown in Scheme 1.
This compound was designed as metallo-b-lactamase inhi-
bitor thanks to its similarity with penicillin V, a b-lactam
antibiotic inactivated by metallo-b-lactamase, for which there
are no commercially available inhibitors (Cornaglia et al.,
2011). In PIMA, the 2-phenoxymethyl-3-H-imidazole mimics
the phenoxyacetylamino group in C6 of penicillin V,
(Scheme 1) according to the well-known bioisosterism of this
five-membered heterocycle with amides (Gordon et al., 1993).
This similarity is also improved by the presence of the car-
boxylic group in position 4 of imidazole, recalling the hydrol-
ysis product of penicillin V. Since in metallo-b-lactamase the
catalytically active Zinc atom is coordinated by the penicillinN
O
O
OHO
N
H
S
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H
ase
O
N
N
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PIMA
H
3-H-imidazole-4-carboxylic acid (PIMA) with Penicillin V.
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represent a substrate analog inhibitor. In addition, this mole-
cule represents a potential polydentate agent able to chelate
metal ions in biological systems thanks to the presence in the
molecular skeleton of donor atoms such as imidazole nitro-
gens, carboxylic oxygens and phenoxymethyl group. For all
these reasons the evaluation of PIMA coordinating ability
toward metal ions is of great relevance; hence, the solution
study on Zn2+, Fe3+ and Ga3+ containing systems is here
reported together with DFT calculation.
2. Materials and methods
2.1. Synthesis
PIMA was obtained following Scheme 2.
The imidazole carboxylate (1), precursor of PIMA, can be
easily obtained by one-pot reaction of a suitable 1,2-diaza-
1,3-diene with 2-phenoxy-acetaldehyde and benzylamine as
already described (Preti et al., 2010). The reaction implies the
1,5-electrocyclization of the in situ formed azavinyl azome-
thine ylide, promoted by microwave irradiation. The described
intermediate 1 simply requires two deprotection steps to obtain
the final compound: an initial hydrolysis furnishes the carboxy
group, while the subsequent debenzylation unmasks the NH of
imidazole.
Ethyl 3-benzyl-5-methyl-2-phenoxymethyl-3-H-imidazole-
4-carboxylate (1) (840 mg, 2.40 mmol) was treated with a 2 M
solution of sodium hydroxide in ethanol (3 mL, 6.00 mmol)
and heated at reflux temperature for 2 h. The reaction mixture
was then partitioned between water (20 mL) and diethyl ether
(20 mL) and the aqueous phase was acidified with HCl 5%
w/w. The precipitate formed was filtered and dried in vacuo
overnight affording 3-Benzyl-5-methyl-2-phenoxymethyl-3H-
imidazole-4-carboxylic acid (2) as a cream-colored solid
(635 mg, 82%). M.p. 206–208 C. 1H NMR (400 MHz, CD3-
OD): d 2.69 (3H, s, CH3), 5.42 (2H, s, CH2O), 5.92 (2H, s,
NCH2), 6.94 (2H, d, J 7.9, HArom), 7.05 (1H, t, J 7.6, HArom),
7.23 (2H, d, J 6.5, HArom), 7.29–7.40 (5H, m, HArom).
13C
NMR (100 MHz, CD3OD): d 10.5, 49.9, 59.6, 114.5 (2C),
121.6, 122.3, 126.5 (2C), 128.0, 128.7 (2C), 129.5 (2C), 134.3,
137.8, 144.6, 157.0, 159.5. MS (EI): m/z (%) 278 [M–COOH]+
(1), 185 (46), 91 (100), 77 (3), 65 (17).
The previous intermediate 2 (604 mg, 1.87 mmol) was dis-
solved in methanol (120 mL) and palladium catalyst (Pd
(OH)2, 20 wt.% Pd on carbon, 604 mg) was added. The system
was evacuated, purged with hydrogen and vigorously stirred
for 16 h. The reaction mixture was then filtered and concen-
trated under reduced pressure, affording 5-methyl-2-N N
O
EtO
O
NH2
N
EtOOC
O
O
N
COOEt
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Scheme 2 Synthphenoxymethyl-3-H-imidazole-4-carboxylic acid (PIMA) as a
cream-colored solid (360 mg, 83%). M.p. 209–210 C. 1H
NMR (400 MHz, DMSO-d6): d 2.42 (3H, s, CH3), 5.07 (2H,
s, CH2O), 6.98 (1H, t, J 7.5, HArom), 7.05 (2H, d, J 7.5,
HArom), 7.32 (2H, t, J 7.5, HArom).
13C NMR (100 MHz,
DMSO-d6): d 12.3, 62.4, 115.2 (2C), 121.7, 124.2, 130.0 (2C),
138.8, 143.4, 158.3, 163.2. MS (EI): m/z (%) 155 [M–Ph]+
(1), 141 (3), 127 (5), 113 (4), 99 (17), 85 (50), 71 (69), 57
(100), 43 (61). Anal. Calculated for C12H12N2O3: C 62.00, H
5.21, N 12.12. Found%: C 61.72, H 5.18, N 12.87.
2.2. Potentiometric measurements
The aqueous solution of the PIMA (5.0  103 M) was
obtained by water dilution of a methanolic solution
(5.0  102 M); the concentration was determined potentio-
metrically. The percentage of methanol in the final solution
was 10%. Potentiometric measurements were performed in
aqueous solution at 25.0 ± 0.1 C, using a fully automated
ORION 960 Autochemistry System following the general pro-
cedures previously reported (Menabue et al., 1998). All exper-
iments were carried out in a nitrogen atmosphere at an ionic
strength of 0.1 M (adjusted with solid NaNO3). Aqueous
NaOH (0.01 M) or HNO3 (0.01 M) was used as titrant. Ten
titrations were performed with 40 data points in each titration
in the range of pH 1–9. The protonation constants (bpq) are
defined in the following equations:
pLþ qH$ LpHq ð1Þ
bpq ¼ ½LpHq=½Lp½Hq ð2Þ
where L is the ligand in the completely dissociated form andH is
a proton Logbpq values were refined by least-squares calculation
using the computer programHYPERQUAD(Gans et al., 1996).
2.3. Spectrophotometric measurements
UV–vis spectrophotometric measurements were performed
using a Jasco V-570 spectrophotometer at 25 ± 0.1 C in the
200–400 nm spectral range employing 1 cm quartz cells.
Spectrophotometric titrations were performed using
5.0  104 M solution of PIMA obtained by water dilution
of a freshly prepared methanolic solution (5.0  102 M) with
addition of an appropriate amount of a aqueous solution of
the metal ion (5  102 M; 1:1, 1:2 and 1:3 M:L molar ratios).
The amount of methanol in the final solution was 1%; hence, it
was used as an aqueous solution. The pH-metric titrations of
the ligand and metal–ligand systems were obtained varying
the pH value by adding small amounts of concentrated NaOHN N
O
HO
O
HN N
O
HO
O
NaOH H2
Pd(OH)2
PIMA2
esis of PIMA.
pH
λ (nm)
Figure 1 Spectrophotometric titration of an aqueous solution of
PIMA 5  104 M, the inset shows the plot of absorbance (A) vs.
pH at k= 260 nm.
1064 C. Romagnoli et al.or HCl in the pH range 2–9 (total number of different pH val-
ues ranging from 20 to 25 in each titration). A constant ionic
strength of 0.1 M (NaNO3) was maintained in all experiments.
Each titration was repeated three times. The overall stability
constants (expressed as logbMLH) were refined from spec-
trophotometric data by least-squares calculation using the
software HypSpec (Gans et al., 1999), and taking into account
the presence of the species [Fe(OH)]2+; [Fe(OH)2]
+; [Fe2
(-
OH)2]
4+ (Escandar et al., 1994).
2.4. NMR spectroscopy
NMR spectra were recorded on a Bruker Avance AMX-400
spectrometer with a Broad Band 5 mm probe in inverse detec-
tion. Nominal frequencies were 100.13 MHz for 13C, and
400.13 MHz for 1H. For each sample, 0.5 mL of mM solution
was prepared in MeOD-d4. The synthesis of Ga
3+:PIMA com-
plex in MeOD-d4 was obtained in situ, by adding to mM ligand
solution (0.5 mL) the proper addition of Ga(NO3)3 solution to
reach the 1:1 metal to ligand molar ratio. Spectra were regis-
tered after few minutes from the addition. Typical parameters
were used for 2D COSY, HSQC, and HMBC experiments.
2.5. Computational details
All calculations were performed with the Gaussian 03 package
of programs (Frisch et al., 2004) and GaussView 03
(Dennington et al., 2003) used as the plotting tool for data
visualization. The computations were performed by DFT
approaches, and the structures were fully optimized using
hybrid-functional B3LYP applied to the 6-311G** basis set
(B3LYP/6-311G**).
3. Results and discussion
3.1. Acid–base equilibria
The acid–base equilibria of PIMA are reported in Scheme 3.
The analysis of potentiometric data yields two pKa values
corresponding to the dissociation of carboxylic and protonated
imidazole groups [pKa1 = 2.78(2), pKa2 = 5.81(2)] (Fig. 1S).
The spectrophotometric titration of PIMA (Fig. 1) shows a
significant increase in absorbance at k 260 nm and k 300 nm
with increasing pH; by plotting A vs. pH a titration trend isScheme 3 Neutral and ionic form of Pobserved although the unique clearly visible equivalent point
is the dissociation of the protonated imidazole group. By pro-
cessing the data with HySpec program (Gans et al., 1999) two
pKa are obtained [pKa1 = 2.91(2) pKa2 = 5.84(2)] whose val-
ues are in good agreement with the potentiometrically found
data. pKa1 value is near to that found for IMA (Sanna et al.,
1998; Va´rnagy et al., 1994) while pKa2 is lower than the value
found for IMA (7.34(1), 7.12(4) (Aljahdali et al., 2013) and is
lower also with respect to free imidazole (6.95) (Va´rnagy
et al., 1994) or imidazole-4-carboxylic acid (6.28) (Podsiadly,
2008). The greater value of IMA with respect to imidazole
was previously attributed to the formation of an intramolecular
hydrogen bond involving the protonated imidazole N and the
carboxylate group (Aljahdali et al.), even though in the crystal
structure of hydrated IMA reported by Okabe and Hayashi
(1999) there is no evidence of intramolecular hydrogen bond.
Hence, the structure of IMA in solution still remains unclear.
In our case, the presence of an electron-withdrawing group
such as the phenoxymethyl contributes to increase the acidity
of NH+ hydrogen.
3.2. Metal complexation
The metal complexation was studied by means of 1H NMR
and spectrophotometric titrations while potentiometric analy-IMA with atom numbering scheme.
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complex species in the investigated pH range.
PIMA shows the typical 1H NMR spectral pattern of sub-
stituted imidazoles (see experimental section). Ga(NO3)3 is
used as NMR probe for Fe3+ (Atkinson et al., 1998; Hara
et al., 2000), and its addition to a solution of PIMA at acidic
pH, immediately originates a complex species, whose spectral
pattern resembles one of the free ligands, but it is downfield
shifted (Fig. 2). The greater downfield shift is observed for
methylenic (H-6) and methylic (H-14) protons, and this behav-
ior should be principally due to the formation of a metal com-
plex, which is in fast exchange with the free ligand in the NMR
timescale.
By reaching the Ga3+:PIMA 1:3 M ratio no further down-
field shift is observed but a new set of signals appears, attrib-
uted to a complex species at M:L 1:2 M ratio while the M:L
1:3 metal complex, observed at downfield, represents a minor
species.
As far as Gallium ion is added a new set of signals which
are attributed to the formation of M:L 1:1 species appears at
higher field than M:L 1:2 complex species. From this point
onward, the metal-complex species present in solution
exchange fast between each other with respect to the NMR
timescale, then the addition of Ga3+ varies speciation distribu-
tion as observed by the change in signals’ integrated areas.
Upon reaching M:L 1:1 the three complex species at M:L
1:1, 1:2 and 1:3 are simultaneously present with the prevalence
of 1:1 and 1:3 M ratio.
The 1H 13C hetero correlated spectra reported in Fig. 3
(Panel A and B) show that the most significant shifts are
observed for H-6 protons while the phenyl protons and C8
are only poorly affected. This finding suggests the involvement5.05.56.06.57.07.58.0
L 
M:L 1:9 
M:L 1:6 
M:L 1:3 
M:L 1:4 
M:L 1:2 
M:L 1:1 
Figure 2 1H NMR titration of PIMA with Ga3+ in MeOD-d4. From
metal ion to the ligand up to metal to ligand 1:1 M ratio (top spectruof both carboxylic group and imidazole nitrogen in metal
coordination with the formation of a five-membered
metallacycle.
Spectrophotometric titration was performed by adding
Ga3+, Fe3+ and Zn2+ to a methanolic-aqueous solution
(1:100 V/V) of the ligand. Fig. 4 reports the spectra of Fe3+:
PIMA system; at each addition of metal ion there is an
increase in absorbance which reaches the maximum value at
the M:L 1:1 M ratio (inset Fig. 4).
Increasing pH in the M:PIMA 1:2 M ratio system for all
metal ions (Fig. 5 reports the titration for Fe3+:PIMA system),
an increase in absorbance at k 300 nm is observed confirming
that the formation of metal complex is pH dependent. At pH 4
the complex species is completely formed as the absorbance
reaches its maximum value. This absorption band was attribu-
ted to the dissociation of protonated imidazole group; there-
fore, we can confirm that metal complexation involves
imidazole nitrogen and the replacement of hydrogen by the
metal ion occurs at a pH value significantly lower compared
to the dissociation of the free ligand (pH  4 vs. pH  5.8).
Over pH 8 the competition with hydroxyl anion becomes sig-
nificant and, in this working concentration, the formation of
metal hydroxide takes place.
From the spectrophotometric titration of Mn+:PIMA sys-
tem in 1:1, 1:2 M ratio for n= 2 and 1:3 M ratio for n= 3
the stability constants of the complex species are evaluated
taking into account different types of protonated and neutral
species; best convergence of data was reached considering
the logb values reported in Table 1.
Fig. 6 reports the species distribution curves for Fe3+,
Ga3+ and Zn2+ containing systems. The prevailing species
in physiological condition is ML3 for Fe
3+ and Ga3+ and2.53.03.54.04.5 ppm
bottom (free ligand), spectra obtained by progressive additions of
m).
H-6; C-6 
ppm
3.03.54.04.55.05.56.06.57.07.58.0 ppm
160
140
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100
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60
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20
ppm
3.03.54.04.55.05.56.06.57.07.58.0 ppm
140
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A 
B 
H-14; C-14 
Figure 3 Panel A: Overlap of 1H–13C HSQC (Hetero-nuclear
Single Quantum Coherence) spectra of free PIMA (red) and
Ga3+:PIMA 1:1 system (black). Panel B: Overlap of 1H–13C
HMBC (Hetero-nuclear Multiple Bond Coherence) spectra of free
PIMA (red) and Ga3+:PIMA 1:1 system (black). All spectra were
acquired in MeOD-d4 at 298 K.
[Fe3+]
λ (nm)
Figure 4 Spectrophotometric titration of PIMA 5  104 M
with Fe3+, [Fe3+] increasing from bottom to top. Inset shows the
plot of absorbance (A) vs. M/L molar ratio at k 300 nm.
Figure 5 pH-metric spectrophotometric titration of Fe3+:PIMA
system in 1:2 M ratio, inset shows the plot of absorbance vs. pH at
k 300 nm; [Fe3+] 2.5  104 M.
1066 C. Romagnoli et al.ZnL2, in which PIMA coordinates the metal ion through
deprotonated carboxylic oxygen and imidazole nitrogen, as it
was proposed by NMR data.The formation of a chelate complex is consistent with the
high logKZnZnL QUOTE value compared to QUOTE logK
H
HL
of PIMA as suggested by Sigel et al. (2000). This coordination
behavior was found also for imidazole-4-carboxylic acid
toward V3+ ion in solution (Podsiadly, 2008). In the solid state
IMA forms chelate complexes with Co2+ and Mn2+ ions
(Kurdziel et al., 2003) while with Zn2+, in acidic conditions,
it was found to give polymeric arrangement in which one anio-
nic ligand molecule bridges two Zn(II) ions and the second
neutral ligand acts as monodentate through carboxylic oxygen
(Dro _zd_zewski et al., 2002). The stability constants of Zn(II)
complexes are comparable to those found for the correspond-
ing species with IMA by To¨ro¨k et al. (1998) (logb110 3.81 and
logb120 7.15), in which the suggested N,O coordinating mode
was attributed to imidazole nitrogen and carboxylic oxygen.
A comparison with similar, but not imidazole-based ligands,
such as b-ala, evidences how the imidazole ring greatly
increases the stability of metal complexes.
The stability constants of Fe3+ PIMA complexes are simi-
lar to those observed by Farkas et al. (2007) for the corre-
sponding complexes with imidazole-4-carbohydroxamic acid
(logb110 10.46(1) and log logb111 12.1(1)) in which the chelate
coordination mode involves only Ohydroxamate atoms. In the
investigated system, imidazole-4-carbohydroxamic acid
resulted competitive with hydroxide ion in binding Fe(III),
and precipitation phenomena were attributed to the formation
of low water-soluble polynuclear complexes rather than iron-
hydroxo species. The logb110 for PIMA is greater than the cor-
responding one for carboxylate complexes, and this suggests a
possible involvement of imidazole nitrogen in stabilizing the
metal complex, and particularly a remarkable p-acceptor prop-
erty of imidazole ring, as suggested by To¨ro¨k et al. (1998). The
precipitation of hydroxo species was only observed above pH
9, suggesting the immobilization of iron by PIMA in the exper-
imental conditions applied for spectrophotometric titrations.
Differently from the cited system, in our case also a FeL3 com-
plex is found, which prevails at physiological pH as well as for
Ga3+, consistently with NMR data. Ga3+ ion gives less stable
species than Fe3+; this trend was previously found for other
chelated complexes with O-donor ligands (Ferrari et al.,
2013). According to species distribution curves, PIMA seems
a good iron chelator at physiological pH, at least in the exper-
Table 1 Logarithms of protonation constants of PIMA and logarithms of formation constants of metal complexes at 25 C,
I= 0.1 M (NaNO3).
logbMHL Fe
3+ Ga3+ Zn2+
HL logb011 5.84(2)
H2L
+ logb012 8.75(2)
ML2+ logb110 11.34(2) 10.71(4) ZnL
+ 5.01(1)
MHL3+ logb111 14.23(2) 14.01(2) ZnHL
2+ 7.80(2)
ML2
+ logb120 20.21(3) 19.87(2) ZnL2 9.81(2)
M(HL)2
3+ logb122 28.01(2) 27.84(3) Zn(HL)2
2+ 14.3(1)
ML3 logb130 24.72(3) 23.89(3)
M(HL)3
3+ logb133 41.20(2) 40.12(2)
Synthesis, characterization and metal coordination of inhibitor 1067imental conditions applied for spectrophotometric measure-
ments. A more proper indicator of the Fe3+ sequestering abil-
ity in physiological conditions is represented by pFe3+ defined
as –log[Fe3+] (Liu and Hider, 2002).Figure 6 Species distribution curves for M:L systems
[M]tot = 2.5  104; [L]tot = 5  104.Table 2 reports the pFe3+ values for several hexadentate
and bidentate ligands, which are effective iron chelators for
therapeutic applications (Liu and Hider, 2002). Hexadentate
ligands show greater pFe3+ values but they have the disadvan-
tage of a high molecular weight.
Among bidentate ligands hydroxypyridinones present a
great effectiveness in iron chelation conjugated with a low
molecular mass. The key property for orally active iron chela-
tor is its ability to be efficiently absorbed from the gastroin-
testinal tract (GIT) and to cross biological membranes. The
molecular size is a critical factor, which influences the rate of
drug absorption: with respect to the molecular weight ‘‘cut-o
ff’’ (ca. 500 Da) for the paracellular route absorption in the
human small intestine (Liu and Hider, 2002) PIMA (232 Da)
could reach the target sites at sufficient concentration.
3.3. DFT calculations
Fig. 7 shows the optimized structures for different conformers
of PIMA and Table 3 reports the total energy values (E) and
relative energy values (DE) of the different conformers and rel-
ative monoanion. The most stable conformer A is probably
stabilized by an attractive interaction involving H(N3) and
carboxylic oxygen, in addition to the planarity of the molecule,
shown by the dihedral angle N3–C2–C6–O7 (Table 2, atom
numbering as in Scheme 2). A similar interaction was found
in a theoretical study on different imidazole carboxylic acids
(Alkorta and Elguero, 2005).
Previous crystal data of imidazole-4-acetic acid monohy-
drate showed IMA in the zwitterionic form in the solid stateTable 2 Comparison of pFe3+ values and stability constants
for bidentate (b) and hexadentate (h) ligands. Values taken
from Liu and Hider (2002).
Ligand Denticity logb13 pFe
3+
PIMA b 24.72 17
DMB (N,N-dimethyl-2,3-
dihydroxybenzamide)
b 40 15
1-Methyl-3-hydroxy-4-pyridinone b 32 16
1,2-Dimethyl-3-hydroxy-4-
pyridinone
b 37.2 19
MECAM (mesitylene
catecholamine)a
h 43 28
DFO (desferrioxamine)a h 31 26
pFe3+ = log [Fe3+ ]; [Fe3+]total = 106 M; [L]total = 105 M;
pH 7.4.
a logb is referred to 1:1 complex.
1068 C. Romagnoli et al.(Okabe and Hayashi, 1999) stabilized by hydrogen bonds
involving water molecules. In the anionic form of both A
and B conformers the planarity of the molecule is removed
being the dihedral angle of 68.80 and 52.72 respectively, even
if the hydrogen bond interaction between H(N3) and car-
boxylic oxygen is retained.
In order to calculate the most plausible structure of PIMA
metal complexes, we have taken into account the B(H1)
anion, which is the only one able to interact with metal ion
leading to the formation of a chelate complex. Actually, the
involvement of N3 in metal coordination requires the proton
dissociation that cannot be proposed under the pH conditions
in which the present study was carried out.A
A1
Z
Figure 7 Optimized structures at B3LYP/6-31G** level o
Table 3 B3LYP/6-311G** total energy E (a.u.) and relative energy
monoanion. A, B, and Z conformers are referred to Fig. 7; dihedral
Neutral PIMA P
E (a.u.) DE (kcal/mol) Dihedral angle ()
A 799.719735 0 0 A
A1 799.719400 0.21 23.56 B
B 799.718915 0.52 24.03
B1 799.712751 4.38 23.56
Z 799.674572 28.34 0.13
Z1 799.678193 26.07 7.63Considering the stoichiometry of the prevailing species at
physiological pH and assuming the coordination mode sug-
gested by NMR data we also calculated the structure for Ga
(PIMA)3 shown in Fig. 8, together with the total energy value
(E) and the binding energy value (BE) of the complex. Appar-
ently, no examples of DFT calculations on Ga(III) complexes
with N,O donor atoms are reported in the literature; however,
the BE value of Ga(PIMA)3 is of the same order of magnitude
with respect to that found for Ga(III) complexes with cur-
cumin 1347.73 kcal/mol and curcumin derivatives
1354.22 kcal/mol (Ferrari et al., 2014).B
B1
f different tautomers of PIMA and its monoanion (Z).
DE (kcal/mol) for different conformers of neutral PIMA and its
angle N3–C2–C6–O7.
IMA anion
E (a.u.) DE (kcal/mol) Dihedral angle ()
(H1) 799.157108 0 68.80
(H1) 799.132914 15.18 52.72
Figure 8 Optimized structures at B3LYP/6-31G** level of Ga
(PIMA)3 complex. TEc – 4320.481825 (a.u.); BE 1452.61
(kcal/mol). Where BE = TES – TEC where TES = sum of the
total electronic energy of the bare metal ion and the relative isomer
of the complexing anion (a.u.); TEC = total electronic energy of
complexes (a.u.).
Synthesis, characterization and metal coordination of inhibitor 10694. Conclusions
UV–vis and NMR spectroscopic data highlighted that PIMA
exhibits an efficient metal chelating ability toward different
metal ions of great biological relevance such as iron and zinc.
The good stability of the formed complexes at physiological
pH suggests the possible use of PIMA for therapeutic applica-
tions as chelator, especially for iron. In particular, the demon-
strated ability of PIMA to chelate zinc ion, combined with its
structure similarity with penicillin V, supports further explo-
ration of this imidazole-4-carboxylate as metallo-b-lactamase
inhibitor.
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